Diet, exercise, and C-reactive protein levels in people with abdominal obesity: The ATTICA epidemiological study

Angiology

Volumn 58, Issue 2, 2007, Pages 225-233

  Pitsavos, Christos ^a   Panagiotakos, Demosthenes B ^a,b,d   Tzima, Natalia ^b   Lentzas, Yannis ^a   Chrysohoou, Christina ^a   Das, Undurti N ^c   Stefanadis, Christodoulos ^d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c UND LIFE SCIENCES   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIET; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GREECE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; NUTRITIONAL ASSESSMENT; PHYSICAL ACTIVITY; SCORING SYSTEM; SEX DIFFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD PRESSURE DETERMINATION; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DIET, MEDITERRANEAN; EXERCISE; FEMALE; GREECE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; QUESTIONNAIRES;

EID: 34247565226     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707300014     Document Type: Article

References (34)

1. Shirai K.: Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 20: 295-304, 2004.
2. Must A., Spadano J., Coakley EH,, et al. The disease burden associated with overweight and obesity. JAMA 282: 1523-1529, 1999.
3. World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation presented at the World Health Organization; June 3-5, 1997 ; Geneva, Switzerland; Publication WHO /NUT/NCD/98.1.
4. Eckel RH, Krauss RM: American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. Circulation 97: 2099-2100, 1998.
5. Elisaf M.: The treatment of coronary heart disease: An update. Part 1: An overview of the risk factors for cardiovascular disease. Curr Med Res Opin 17: 18-26, 2001.
6. Smith SC Jr, Anderson JL, Cannon RO III,, et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report from the Clinical Practice Discussion Group. Circulation 110: e550 - e553, 2004.
7. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363-369, 2003.
8. Dobbelsteyn C., Joffres M., MacLean D., et al: A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors: The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord 25: 652-661, 2001.
9. Guidelines for the Data Processing and Analysis of the International Physical Activity Questionnaire. Available at: www.ipaq.ki.se. Accessed January 2006.
10. Katsouyanni K., Rimm EB, Gnardellis C.,, et al. Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. Int J Epidemiol 26: S118 - S127, 1997.
11. Pitsavos C., Panagiotakos DB, Chrysohoou C., Stefanadis C.: Epidemiology of cardiovascular risk factors in Greece: Aims, design and baseline characteristics of the ATTICA Study. BMC Public Health 3: 1-9, 2003.
12. World Heart Organization Study Group: Diet, Nutrition, and the Prevention of Chronic Diseases. Geneva, Switzerland: World heart Organization ; Technical Report Series, 797 ; 1990.
13. Chrysohoou C., Panagiotakos DB, Pitsavos C., Das UN, Stefanadis C.: Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 2004 ; 44: 152-158.
14. Esposito K., Marfella R., Ciotola M.,, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 292: 1440-1446, 2004.
15. Nicklas BJ, You T., Pahor M.: Behavioural treatments for chronic systemic inflammation: Effects of dietary weight loss and exercise training. Can Med Assoc J 172: 1199-1209, 2005.
16. Sesso HD, Buring JE, Rifai N.,, et al. C-reactive protein and the risk of developing hypertension. JAMA 290: 2945-2951, 2003.
17. Ridker PM, Buring JE, Cook NR, Rifai N.: C-reactive protein, the metabolic syndrome, and the risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 107: 391-397, 2003.
18. Kullo IJ, Seward JB, Bailey KR,, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 18: 1123-1129, 2005.
19. Grundy SM: Inflammation, hypertension, and the metabolic syndrome. JAMA 290: 3000-3002, 2003.
20. Wisse BE: The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15: 2792-2800, 2004.
21. Reaven GM: Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88: 2399-2403, 2003.
22. Esposito K., Giugliano D.: The metabolic syndrome and inflammation: Association or causation? Nutr Metab Cardiovasc Dis 14: 228-232, 2004.
23. Garner B., Witting PK, Waldeck AR,, et al. Oxidation of high density lipoproteins: I: Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J Biol Chem 273: 6080-6087, 1998.
24. Schulze MB, Rimm EB, Shai I., Rifai N., Hu F.: Relationship between adiponectin and glycemic control, blood lipids and inflammatory markers in men with type 2 diabetes. Diabetes Care 27: 1680-1687, 2004.
25. Ravin KR, Kamari Y., Navni I., Grossman E., Sharabi Y.: Adiponectin: Linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther 3: 465-471, 2005.
26. Schneider JG, von Eynatten M., Schekofer S., Nawroth P., Dugi KA: Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 28: 2181-2186, 2005.
27. Festa A., D'Agostino R., Willimas K.,, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes 25: 1407-1415, 2001.
28. Forouhi NG, Sattar N., McKeigue PM: Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes 25: 1327-1331, 2001.
29. Hotamisligil GS, Arner P., Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
30. Purhoit A., Ghilchik MW, Duncan L.,, et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissue. J Clin Endocrinol 9: 61-72, 1995.
31. Baumann H., Gauldie J. The acute-phase response. Immunol Today 25: 74-80, 1994.
32. Panagiotakos DB, Pitsavos C., Chrysohoou C.,, et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA Study. Am Heart J 147: 106-112, 2004.
33. Athyros VG, Bouloukos VI, Pehlivanidis AN,, et al. The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes Metab 7: 397-405, 2005.
34. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002.